MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2026 International Congress

    One day accelerated 10 Hz rTMS for Focal Hand Dystonia: A Phase II Clinical Trial

    I. Xu, Z. Simsek, P. Mulcahey, C. Bui, Y. Li, N. Hamzah, A. Norain, M. Lipp, D. Bitlis, S. Dave, K. Grozev, C. Russell, C. Petty, M. Lutz, A. Peterchev, N. Bukhari-Parlakturk (Durham, USA)

    Objective: To evaluate the efficacy of four sessions of 10 Hz repetitive transcranial magnetic stimulation delivered in one day (rTMS) to patients with focal hand…
  • 2026 International Congress

    Treatment Patterns in Adults with Isolated Dystonia in the United States

    M. Oldham, J. Kerner, S. Dasgupta, J. Imperato, J. Thornton (Cambridge, USA)

    Objective: To characterize real-world treatment patterns in adults with isolated dystonia in the United States. Background: Isolated dystonia is a rare, complex movement disorder characterized…
  • 2026 International Congress

    Dystonias in a Nigerian Tertiary Hospital: A Case Series Highlighting Diagnostic and Therapeutic Challenges and a Five-Year Retrospective Review

    I. Ndionuka, C. Okereke, K. Onwuka, K. Okorie, I. Onwuekwe (Enugu State, Nigeria)

    Objective: To describe three clinically diverse cases of dystonia managed at a Nigerian tertiary hospital and present findings from a five-year retrospective review of dystonia…
  • 2026 International Congress

    Levodopa-Responsive Dystonia in Adenylosuccinate Lyase (ADSL) Deficiency Treated With Bilateral GPi Deep Brain Stimulation

    K. Ibarra, M. San Luciano (San Francisco, USA)

    Objective: To describe levodopa-responsive dystonia in ADSL deficiency and the use of bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) for refractory symptoms. Background:…
  • 2026 International Congress

    Globus Pallidus Internus Deep Brain Stimulation for Dystonia in COX20-Related Mitochondrial Complex IV Deficiency (MC4DN11): First Reported Case

    R. Toklu çetinkaya, N. Durmaz çelik, S. özkan (eskişehir, Turkey)

    Objective: To describe the clinical response to bilateral GPi-DBS in a patient with MC4DN11-associated dystonia. Background: Mitochondrial Complex IV Deficiency, Nuclear Type 11 (MC4DN11), caused…
  • 2026 International Congress

    Phenotypic Spectrum, Neuroimaging Findings, Genotypic Correlates, and Treatment Outcomes in KMT2B-Related Disorder: A Multicenter Retrospective Cohort Study

    S. Roychowdhury, H. Alfaris, A. Menetrey, D. Munoz, P. Bisarad, M. Huynh, J. Ganguly, M. Kruer, A. Leblanc-Millar, G. Ibrahim, C. Gorodetsky (Toronto, Canada)

    Objective: The primary objective is to describe movement disorder phenomenology, genotypic correlates and treatment outcomes in patients with KMT2B-related disorder. Background: KMT2B-related dystonia is a…
  • 2026 International Congress

    Disparities for Tremor and Dystonia Patients Accessing Deep Brain Stimulation: An Explanatory Sequential Mixed Methods Study

    S. Corrick, J. Miyasaki, A. Hyde, S. Poonja, B. Duad Shah, E. Noyes, P. Torabi, K. Yen, G. Dimapilis, T. Sankar, A. Rajput, A. Vitali, B. Oladunni Salami, F. Ba (Edmonton, Canada)

    Objective: The objective of this study is to better characterize the disparities for DBS access using a mixed-methods approach to quantify and understand demographic differences…
  • 2026 International Congress

    Long‑term dose-effect patterns with incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in cervical dystonia: multicenter real‑world analysis

    B. Waeschle, P. Albrecht, J. Lee, T. Kölsche, R. Jansen, P. Sobolewski, S. Sánchez Valiente, E. López Valdés, P. Mir, S. Jesús, E. Ojeda Lepe, E. Papuć, P. Sánchez Alonso, G. Salazar, G. Comes, H. Stark (Frankfurt, Germany)

    Objective: To characterize long‑term dose-effect patterns for incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in cervical dystonia (CD) using a unified dose-effect parameter (DEff) and to compare complex‑free…
  • 2026 International Congress

    Safety and Effectiveness of DaxibotulinumtoxinA in Cervical Dystonia: A Systematic Review and Meta-Analysis of Different Doses

    H. Sabet, M. Aziz, M. Zanaty (Qena, Egypt)

    Objective: To evaluate the effectiveness and safety of DaxibotulinumtoxinA (DAXI) in patients diagnosed with cervical dystonia (CD). Background: Botulinum toxins (BoNTs) are the first-line therapy…
  • 2026 International Congress

    Short Term Effects of Wearable Vibrotactile Stimulation in Laryngeal Dystonia

    N. Doan, K. Vo, T. Dang, U. Ha, T. Nguyen, T. Tran (Ho Chi Minh City, Viet Nam)

    Objective: To evaluate the short-term efficacy of a wearable vibrotactile stimulation (VTS) device in patients with laryngeal dystonia (LD) prior to botulinum toxin (BoNT) injection,…
  • 1
  • 2
  • 3
  • …
  • 43
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley